European Haemophilia Consortium (EHC)
Search

Bayer Initiates Phase III Trial of New Recombinant Factor VIII Compound for Treatment of Hemophilia -- BAY94-9027

prsync.com/bayer/not-intended-for-us-and-uk-media----bayer-initiates-phase-iii-trial-of-new-recombinant-factor-viii-compound-for-treatment-of-hem-464360/